Yunjie Zeng
Overview
Explore the profile of Yunjie Zeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
800
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gong C, Xia Y, Zhu Y, Yang Y, Lin Q, Liu Q, et al.
Cell Rep Med
. 2024 Nov;
5(11):101807.
PMID: 39510070
The prognosis of patients with luminal/human epidermal growth factor receptor 2 (HER2)-low early breast cancer (EBC) needs to be improved. This preclinical study and phase 2 trial (ChiCTR2100047233) aims to...
2.
Zeng Y, Liu H, Hu J, Zhao Z, She Q
Sci Rep
. 2024 Aug;
14(1):19888.
PMID: 39191858
This study introduces a novel self-supervised learning method for single-frame subtraction and vessel segmentation in coronary angiography, addressing the scarcity of annotated medical samples in AI applications. We pretrain a...
3.
Liu D, Zeng Y, Liang P, Jiang Y, An S, Ren P
Medicine (Baltimore)
. 2022 Nov;
101(43):e31235.
PMID: 36316861
Background: Despite advances in treatment strategies for coronary heart disease, angina pectoris remains a major cardiovascular disease causing death worldwide. For patients with angina pectoris of coronary heart disease, new...
4.
Gong C, Cheng Z, Yang Y, Shen J, Zhu Y, Ling L, et al.
Sci China Life Sci
. 2022 May;
65(11):2205-2217.
PMID: 35579777
Patients with hormone receptor (HR)-positive tumors breast cancer usually experience a relatively low pathological complete response (pCR) to neoadjuvant chemotherapy (NAC). Here, we derived a 10-microRNA risk score (10-miRNA RS)-based...
5.
Xiong B, Yang H, Yu W, Zeng Y, Han Y, She Q
Front Cardiovasc Med
. 2022 May;
9:735636.
PMID: 35497976
Background: The optimal revascularization strategy in patients with ST-segment elevation myocardial infarction (STEMI) complicating by cardiogenic shock (CS) remains controversial. This study aims to evaluate the clinical outcomes of multivessel...
6.
Zeng Z, Li M, Zeng Y, Zhang J, Zhao Y, Lin Y, et al.
Evid Based Complement Alternat Med
. 2021 Jul;
2021:9994824.
PMID: 34257697
Background: Acupuncture is considered a complementary therapy for atopic eczema. The aim of this scoping review is to identify, examine, and summarize the potential acupoint prescriptions and outcome reporting regarding...
7.
Lu Y, Zhao Q, Liao J, Song E, Xia Q, Pan J, et al.
Cell
. 2020 Mar;
180(6):1081-1097.e24.
PMID: 32142650
Understanding molecular mechanisms that dictate B cell diversity is important for targeting B cells as anti-cancer treatment. Through the single-cell dissection of B cell heterogeneity in longitudinal samples of patients...
8.
Su S, Liao J, Liu J, Huang D, He C, Chen F, et al.
Cell Res
. 2017 Mar;
27(4):461-482.
PMID: 28290464
The origin of tumor-infiltrating Tregs, critical mediators of tumor immunosuppression, is unclear. Here, we show that tumor-infiltrating naive CD4 T cells and Tregs in human breast cancer have overlapping TCR...
9.
Liu J, Su Z, Zeng Y, Zhang H, Yang S, Liu G
Oncol Rep
. 2017 Feb;
37(3):1445-1450.
PMID: 28184924
Evidence reveals that microRNAs (miRNAs) play essential roles in hepatocellular carcinoma (HCC) tumorigenesis. In the present study, we identified an essential role for miR-922 in the development of HCC. We...
10.
Gong C, Tan W, Chen K, You N, Zhu S, Liang G, et al.
EBioMedicine
. 2016 Aug;
11:199-209.
PMID: 27566954
Purpose: Breast cancer patients with high proportion of cancer stem cells (BCSCs) have unfavorable clinical outcomes. MicroRNAs (miRNAs) regulate key features of BCSCs. We hypothesized that a biology-driven model based...